Newsroom
Newsroom
Blog Posts
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Blog Posts
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Industry News
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke......
Industry News
Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges......
Industry News
Zack McGahey was named COO and will be responsible for all operations functions as the company scales and commercializes its first products. Prior to joining...
Industry News
Antheia CEO Christina Smolke brews up new pharmaceuticals......
Industry News
Ginkgo Bioworks, a Boston-based cell-programming specialist, will deploy its high-throughput enzyme design and screening technology to help the synthetic biology firm Antheia broaden its pipeline...
Industry News
Antheia reconstructs complex biochemical pathways in yeasts to speed up production of natural product-based drugs......
Blog Posts
Antheia was founded in 2015 by Dr. Christina Smolke, CEO and Dr. Kristy Hawkins, CSO and is based in Menlo Park, California. Antheia’s co-founders are...
Blog Posts
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that are changing how we solve global...
Blog Posts
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American bioeconomy and strengthening domestic pharmaceutical...
Blog Posts
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...
Blog Posts
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active pharmaceutical...